Metabolic measures 12 months after a randomised controlled trial of treatment of clozapine associated obesity and diabetes with exenatide (CODEX)

Dan Siskind; A. Russell; C. Gamble; A. Baker; P. Cosgrove; L. Burton; S. Kisely

doi:10.1016/j.jpsychires.2020.02.015

Metabolic measures 12 months after a randomised controlled trial of treatment of clozapine associated obesity and diabetes with exenatide (CODEX)

Dan Siskind, A. Russell, C. Gamble, A. Baker, P. Cosgrove, L. Burton, S. Kisely

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	9-12
Number of pages	4
Journal	Journal of Psychiatric Research
Volume	124
DOIs	https://doi.org/10.1016/j.jpsychires.2020.02.015
Publication status	Published - May 2020
Externally published	Yes

ASJC Scopus Subject Areas

Psychiatry and Mental health
Biological Psychiatry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jpsychires.2020.02.015

Cite this

@article{70910edffd11412d913c0e1e666c77cd,

title = "Metabolic measures 12 months after a randomised controlled trial of treatment of clozapine associated obesity and diabetes with exenatide (CODEX)",

author = "Dan Siskind and A. Russell and C. Gamble and A. Baker and P. Cosgrove and L. Burton and S. Kisely",

note = "Funding Information: The original trial was supported by the Rebecca L. Cooper Medical Research Foundation ; National Health and Medical Research Council , Grant/Award number: ECF APP1111136 ; and the PA Research Foundation . Publisher Copyright: {\textcopyright} 2020 Elsevier Ltd",

year = "2020",

month = may,

doi = "10.1016/j.jpsychires.2020.02.015",

language = "English",

volume = "124",

pages = "9--12",

journal = "Journal of Psychiatric Research",

issn = "0022-3956",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Metabolic measures 12 months after a randomised controlled trial of treatment of clozapine associated obesity and diabetes with exenatide (CODEX)

AU - Siskind, Dan

AU - Russell, A.

AU - Gamble, C.

AU - Baker, A.

AU - Cosgrove, P.

AU - Burton, L.

AU - Kisely, S.

N1 - Funding Information: The original trial was supported by the Rebecca L. Cooper Medical Research Foundation ; National Health and Medical Research Council , Grant/Award number: ECF APP1111136 ; and the PA Research Foundation . Publisher Copyright: © 2020 Elsevier Ltd

PY - 2020/5

Y1 - 2020/5

UR - http://www.scopus.com/inward/record.url?scp=85079537352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079537352&partnerID=8YFLogxK

U2 - 10.1016/j.jpsychires.2020.02.015

DO - 10.1016/j.jpsychires.2020.02.015

M3 - Article

C2 - 32087425

AN - SCOPUS:85079537352

SN - 0022-3956

VL - 124

SP - 9

EP - 12

JO - Journal of Psychiatric Research

JF - Journal of Psychiatric Research

ER -

Metabolic measures 12 months after a randomised controlled trial of treatment of clozapine associated obesity and diabetes with exenatide (CODEX)

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this